GoIndustry DoveBid appoints SVP of North American sales

Romie Castelli returns to the company he originally joined in 2002

GoIndustry DoveBid, a provider of asset management services for industrial companies, has appointed Romie Castelli as senior vice president of North American sales.

Castelli takes responsibility for directing GoIndustry DoveBid’s sales and marketing efforts in North America. He was most recently senior vice president of corporate services at Great American Group. Before that, as senior vice president of North America at DoveBid, prior to its acquisition by GoIndustry in 2008, he was responsible for the DoveBid sales force.

Castelli joined DoveBid in 2002 through acquisition, having been vice president of sales for ZoneTrader.

You may also like

Finance

Sanofi completes acquisition of Blueprint Medicines

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company specialising in systemic mastocytosis (SM) and other KIT-driven diseases
Finance

Evestia Clinical to merge with Atlantic Research Group

The merger delivers on Evestia Clinical’s strategy of targeted growth through the expansion of services, enhanced technology and broadened geographical reach
Research & Development

Amphista Therapeutics reaches research milestone and triggers a milestone payment from Merck

Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications
Manufacturing

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
Research & Development

Strategic investment by Bain Capital, Kohlberg and Mubadala fuels PCI Pharma Services’ expansion

This financial injection is expected to cement PCI’s position in the CDMO arena
Finance

Pila Pharma bags nearly £1.5m to aid obesity drug development

The ex-Novo Nordisk researcher-founded biotech will use the money to expand its obesity clinical pipeline
Research & Development

Ofichem Group to acquire drug formulation development specialist, Avivia

Ofichem will now be able to offer its clients a range of early-stage development services, from analytical method development to excipient characterisation
Subscribe now